Onsite vs. Virtual Group Fitness in Overweight/Obese Women

Not Applicable

Completed

• Conditions: Overweight and Obesity

• Registration Number: NCT04974476
• Lead Sponsor: University of Miami

Brief Summary

The purpose of this study is to compare an onsite to virtual whole-body high intensity interval training (HIIT) program on anthropometric variables, aerobic fitness measures, and vascular markers of cardiac risk in a single study of overweight and obese women.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-07-14
• Study First Submitted QC: 2021-07-14
• Study First Posted: 2021-07-23
• Study Start: 2021-07-24
• Status Verified: 2021-11
• Primary Completion: 2021-11-08
• Study Completion: 2021-11-08
• Last Update Submitted: 2021-11-09
• Last Update Posted: 2021-11-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 35

Inclusion Criteria

• Premenopausal adult females over the age of 18 and under the age of 45 with a BMI greater than or equal to 25 and a waist circumference greater than or equal to 35 inches.
• No medical contraindications to participation in an exercise program including major medical illnesses (i.e. cardiovascular disease, stroke, cancer, etc.)
• Ability to provide informed consent
• Willingness and ability to participate in an interval training in-person group fitness exercise program 3x/week for 12 weeks

Exclusion Criteria

• Adults unable to consent or mini-mental score less than 18.
• Individuals who are not yet adults (infants, children, teenagers)
• Pregnant women
• Post-menopausal women
• Do not speak English
• Prisoners
• Subjects on medicines (serum glucose, insulin, weight loss medicines, beta-blockers) and having any medical pre-conditions that would interfere with one's capacity to exercise.
• Answer "Yes" to any of the questions on the Pre-Activity Screening Questionnaire (PASQ)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Pulse Wave Analysis Mean Arterial Pressure (MAP)	Up to 12 weeks	vascular marker of cardiac risk will be reported as MAP (mmHg) as measured using SphygmoCor
Total Adiposity	Up to 12 weeks	Anthropometric measure will be reported as Total Adiposity as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer
Pulse Wave Velocity (PWV)	Up to 12 weeks	vascular marker of cardiac risk will be reported as PWV (m/s) as measured using SphygmoCor
Visceral Adipose Tissue (VAT) content	Up to 12 weeks	Anthropometric measure will be reported as VAT content as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer
Aerobic Fitness	Up to 12 weeks	Aerobic Fitness level as measured by the 20 meter shuttle run
Pulse Wave Analysis Augmentation Index (AIx)	Up to 12 weeks	vascular marker of cardiac risk will be reported as AIx (%) as measured using SphygmoCor

Trial Locations

Locations (1)

University of Miami; 🇺🇸 Coral Gables, Florida, United States